nanobody-based Covid-19 therapeutic / Lumen Bio - LARVOL DELTA

Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic (Businesswire) - "Lumen Bioscience...and the US Army Medical Research and Development Command (USAMRDC)...today announced an agreement to develop a rapid, scalable, and inexpensive biologic drug cocktail....The nearly $4 million grant funds rapid development of an oral SARS-CoV-2 treatment and preventative product candidates through FDA Investigational New Drug (IND) submission....By spring 2021 the program aims to initiate Phase 2 clinical trials and complete siting and engineering work for a 1-billion-dose-per-year production facility, with cGMP manufacturing to commence in summer 2021."

Grant • Licensing / partnership • New P2 trial • Infectious Disease • Novel Coronavirus Disease